Clinical use of the III generation calcium antagonist Amlotopin the treatment of patients with cardiovascular disease
Despite the facts, revealing the mechanisms of pathogenesis and enhancing the effectiveness of the treatment of cardiovascular disease (CVD), the latter continues to be the leading cause of death and disability in the population. In this regard, the search for new treatments for CVD remains the most...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Concilium Medicum
2013-12-01
|
| Series: | КардиоСоматика |
| Subjects: | |
| Online Access: | https://cardiosomatics.orscience.ru/2221-7185/article/view/45033 |